StudyFinder

Continuous Glucose Monitor Derived Glucose Dynamic Index as a Diagnostic Marker for Progression to Type 1 Diabetes (Dx-T1D)

Status: Recruiting

This study is being done to develop a way to use information from a continuous glucose monitor (CGM) to predict a person’s progression through the Stages of Type 1 Diabetes (T1D). A CGM is a wearable device that continuously measures and displays a person’s blood sugar levels throughout the day and night by sensing the glucose (blood sugar levels) in the fluid under the skin, providing real-time updates without the need for finger pricks.

I'm interested

Sex: Male or Female
Age Group: Not specified
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• ≥2 years of age and older
• participants in Stage 1 or Stage 2 T1D monitored in the Pathway to Prevention (PTP) study at a TrialNet center
• willing to use a continuous glucose monitoring (CGM) system with a compatible smartphone for glucose data collection
Exclusion Criteria:

• history of diabetes
• women who are pregnant
• allergy to adhesives
Conditions:

Diabetes & Endocrine

Keywords:

Diabetes, T1D, Type 2 Diabetes

Study Contact: Kali Johnson - joh13933@umn.edu
Principal Investigator: Antoinette Moran
IRB Number: STUDY00025616

Back